DRKS00015471
Recruiting
Not Applicable
Multimodal approach in long term longitudinal in-vivo monitoring the clinical outcomes of graft maturation of injected matrix-assisted autologous chondrocyte transplantation in individual patients – clinical, morphological MRI and biochemical quantitative T2-mapping, T1rho and diffusion-weighted-imaging. - ACTIVE
Klinikum der Universität München, Campus Großhadern0 sites30 target enrollmentApril 16, 2019
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- M23.99
- Sponsor
- Klinikum der Universität München, Campus Großhadern
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •minimum age 18 years, maximum age 60 years. Isolated cartilage defect of at least 2 cm² size. ACTinject treatment of the knee at least 3 month previously. Signed informed consent form.
Exclusion Criteria
- •More then 2 cartilage defects. (Osteo\-)arthritis. Instability of the knee joint. Incomplete follow\-up data. General contraindications for MRI.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Effect of an interdisciplinary multimodal long-term weight reduction program on left ventricular diastolic function in morbid obesityI50.12E66.9Obesity, unspecifiedDRKS00003087Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg520
Unknown
Not Applicable
Patients With Chronic Hepatitis B and Low Viremia Not Receiving Antiviral TherapyHepatitis B, ChronicNCT01090531Johann Wolfgang Goethe University Hospital1,000
Recruiting
Not Applicable
A retrospective and prospective longitudinal observational study to assess changes in working capacity related to disease specific factors in Huntington*s diseaseHuntington's Diseasemovement disorder10028037NL-OMON48893eids Universitair Medisch Centrum170
Active, not recruiting
Not Applicable
A Study with additional chart review to evaluate clinical and biochemical characteristics and disease progression in patients with mucopolysaccharidosis type IIIBMucopolysaccharidosis type IIIBE76.2RBR-3rx9fjHospital de Clínicas de Porto Alegre
Active, not recruiting
Phase 1
A study to review Wilson disease patients who have previously been prescribed d- Penicillamine but were changed to trientine as treatment for their disease, and to follow them for a further 12 months.Wilson disease, also known as hepatolenticular degeneration, a rare automsomal, recessively inherited disorder which results in chronic copper intoxication.MedDRA version: 20.0Level: PTClassification code 10019819Term: Hepato-lenticular degenerationSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2013-003564-31-ITIVAR LTD90